LIGAND PHARMACEUTICALS INCORPORATED Pre-Tax Income
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) reported Pre-Tax Income of $64.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was $64.30M, a 472.97% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$24.26M.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was $56.78M.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was $141.14M.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was $158.96M, a 6212.95% increase from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was $2.52M, a 96.04% decline from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was $63.66M, a 76.78% increase from fiscal 2022.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was $36.01M, a 50.13% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $64.30M 10-Q · filed 2026-08-07 | $40.05M 10-Q · filed 2026-08-07 | $96.83M derived: sum of 3 quarters · filed 2026-08-07 | $237.96M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | -$24.26M 10-Q · filed 2026-05-08 | $32.52M derived: sum of 2 quarters · filed 2026-05-08 | $173.66M derived: sum of 3 quarters · filed 2026-05-08 | $184.88M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $56.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $197.92M derived: sum of 2 quarters · filed 2026-02-27 | $209.14M derived: sum of 3 quarters · filed 2026-08-07 | $158.96M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $141.14M 10-Q · filed 2025-11-07 | $152.36M derived: sum of 2 quarters · filed 2026-08-07 | $102.18M 10-Q · filed 2025-11-07 | $62.98M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $11.22M 10-Q · filed 2026-08-07 | -$38.96M 10-Q · filed 2026-08-07 | -$78.16M derived: sum of 3 quarters · filed 2026-08-07 | -$84.50M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | -$50.18M 10-Q · filed 2026-05-08 | -$89.38M derived: sum of 2 quarters · filed 2026-05-08 | -$95.72M derived: sum of 3 quarters · filed 2026-05-08 | -$161.11M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$39.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$45.54M derived: sum of 2 quarters · filed 2026-02-27 | -$110.93M derived: sum of 3 quarters · filed 2026-02-27 | $2.52M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | -$6.34M 10-Q · filed 2025-11-07 | -$71.73M derived: sum of 2 quarters · filed 2025-11-07 | $41.72M 10-Q · filed 2025-11-07 | $58.81M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | -$65.39M 10-Q · filed 2025-08-08 | $48.06M 10-Q · filed 2025-08-08 | $65.15M derived: sum of 3 quarters · filed 2026-02-27 | $53.01M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $113.45M 10-Q · filed 2025-05-09 | $130.54M derived: sum of 2 quarters · filed 2026-02-27 | $118.40M derived: sum of 3 quarters · filed 2026-02-27 | $121.57M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $17.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.95M derived: sum of 2 quarters · filed 2026-02-27 | $8.12M derived: sum of 3 quarters · filed 2026-02-27 | $63.66M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | -$12.14M 10-Q · filed 2024-11-08 | -$8.97M derived: sum of 2 quarters · filed 2024-11-08 | $46.56M 10-Q · filed 2024-11-08 | $70.70M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $3.17M 10-Q · filed 2024-08-07 | $58.71M 10-Q · filed 2024-08-07 | $82.85M derived: sum of 3 quarters · filed 2025-02-28 | $95.20M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $55.54M 10-Q · filed 2024-05-08 | $79.68M derived: sum of 2 quarters · filed 2025-02-28 | $92.03M derived: sum of 3 quarters · filed 2025-02-28 | $100.69M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $24.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $36.49M derived: sum of 2 quarters · filed 2025-02-28 | $45.16M derived: sum of 3 quarters · filed 2025-02-28 | $36.01M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $12.35M 10-Q · filed 2023-11-09 | $857.00K 10-Q · filed 2022-11-08 | $21.02M derived: sum of 2 quarters · filed 2023-11-09 | $11.87M 10-Q · filed 2023-11-09 | -$19.92M 10-Q · filed 2022-11-08 | $29.75M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $8.66M 10-Q · filed 2023-08-09 | -$636.00K 10-Q · filed 2022-08-09 | -$483.00K 10-Q · filed 2023-08-09 | -$20.78M 10-Q · filed 2022-08-09 | $17.40M derived: sum of 3 quarters · filed 2024-02-29 | $32.66M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | -$9.14M 10-Q · filed 2023-05-08 | -$20.14M 10-Q · filed 2022-05-09 | $8.74M derived: sum of 2 quarters · filed 2024-02-29 | $24.00M derived: sum of 3 quarters · filed 2024-02-29 | $57.30M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $17.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $33.14M derived: sum of 2 quarters · filed 2024-02-29 | $66.44M derived: sum of 3 quarters · filed 2024-02-29 | $72.20M 10-K · filed 2024-02-29 | $47.30M 10-K · filed 2022-02-28 | |||
| 2021-09-30 | $15.26M 10-Q · filed 2022-11-08 | $48.56M derived: sum of 2 quarters · filed 2022-11-08 | $54.32M 10-Q · filed 2022-11-08 | $69.52M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $33.30M 10-Q · filed 2022-08-09 | $39.06M 10-Q · filed 2022-08-09 | $54.27M derived: sum of 3 quarters · filed 2023-02-28 | $42.65M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $5.76M 10-Q · filed 2022-05-09 | $20.96M derived: sum of 2 quarters · filed 2023-02-28 | $9.35M derived: sum of 3 quarters · filed 2023-02-28 | |||||
| 2020-12-31 | $15.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $3.59M derived: sum of 2 quarters · filed 2023-02-28 | $1.29M 10-K · filed 2023-02-28 | -$10.54M 10-K · filed 2022-02-28 | ||||
| 2020-09-30 | -$11.61M 10-Q · filed 2021-11-09 | -$13.91M 10-Q · filed 2021-11-09 | ||||||
| 2019-12-31 | $796.64M 10-K · filed 2022-02-28 |